← Back to Search

Behavioral Intervention

AI Chatbot Education for Atrial Fibrillation

N/A
Waitlist Available
Led By Samir Saba, MD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age greater than 18 years
Known diagnosis of atrial fibrillation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from enrollment to end of interaction with chatbot, approximately an hour
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to educate patients with newly diagnosed atrial fibrillation using an AI chatbot that provides information through text and educational videos. Participants must be 18 years or older and agree to interact with

Who is the study for?
This trial is for adults over 18 with a known diagnosis of atrial fibrillation. It's suitable for those who can text and use an electronic device, as well as read English. People unable to interact with technology or who have language barriers are not eligible.
What is being tested?
The study tests the effectiveness of AI chatbot-delivered education on atrial fibrillation. Participants will use an iPad to ask questions about their condition and receive answers with educational content, including video links, during a one-hour session.
What are the potential side effects?
Since this trial involves educational interaction rather than medical treatment, there are no direct physical side effects expected from participating in the study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.
Select...
I have been diagnosed with atrial fibrillation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from enrollment to end of interaction with chatbot, approximately an hour
This trial's timeline: 3 weeks for screening, Varies for treatment, and from enrollment to end of interaction with chatbot, approximately an hour for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Empathy
Secondary study objectives
Knowledge
Trust

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Pilot interventional armExperimental Treatment1 Intervention
Single arm, wherein all consenting participants undergoing interaction with chatbot for atrial fibrillation education.

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,789 Previous Clinical Trials
16,359,583 Total Patients Enrolled
14 Trials studying Atrial Fibrillation
4,586 Patients Enrolled for Atrial Fibrillation
Samir Saba, MDPrincipal InvestigatorUPMC Heart and Vascular Institute
5 Previous Clinical Trials
431 Total Patients Enrolled
1 Trials studying Atrial Fibrillation
12 Patients Enrolled for Atrial Fibrillation
~27 spots leftby Jun 2025